Chison Medical Technologies Co., Ltd. (688358.SS)
CNY 28.08
(-2.4%)
CNY 28.08
(-2.4%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 162.22 Million CNY | 40.9% |
| 2022 | 115.13 Million CNY | 18.78% |
| 2021 | 96.93 Million CNY | -10.9% |
| 2020 | 108.78 Million CNY | -6.2% |
| 2019 | 115.97 Million CNY | 8.68% |
| 2018 | 106.71 Million CNY | 49.19% |
| 2017 | 71.52 Million CNY | 170.79% |
| 2016 | 26.41 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 15.78 Million CNY | -60.23% |
| 2024 Q1 | 52.4 Million CNY | 3367.48% |
| 2024 Q2 | 39.69 Million CNY | -24.25% |
| 2023 Q2 | 69.12 Million CNY | 15.84% |
| 2023 FY | 162.22 Million CNY | 40.9% |
| 2023 Q4 | 1.51 Million CNY | -95.26% |
| 2023 Q1 | 59.67 Million CNY | 342.42% |
| 2023 Q3 | 31.9 Million CNY | -53.84% |
| 2022 Q1 | 29.05 Million CNY | -28.21% |
| 2022 Q4 | -24.61 Million CNY | -148.0% |
| 2022 Q2 | 59.4 Million CNY | 104.44% |
| 2022 FY | 115.13 Million CNY | 18.78% |
| 2022 Q3 | 51.27 Million CNY | -13.69% |
| 2021 FY | 96.93 Million CNY | -10.9% |
| 2021 Q4 | 40.47 Million CNY | 39.74% |
| 2021 Q3 | 28.96 Million CNY | 0.69% |
| 2021 Q1 | 26.81 Million CNY | -20.84% |
| 2021 Q2 | 28.76 Million CNY | 7.27% |
| 2020 FY | 108.78 Million CNY | -6.2% |
| 2020 Q3 | 28.82 Million CNY | 20.7% |
| 2020 Q2 | 23.88 Million CNY | 7.59% |
| 2020 Q1 | 22.19 Million CNY | -49.93% |
| 2020 Q4 | 33.87 Million CNY | 17.52% |
| 2019 FY | 115.97 Million CNY | 8.68% |
| 2019 Q4 | 44.33 Million CNY | 65.58% |
| 2019 Q3 | 26.77 Million CNY | -27.59% |
| 2019 Q2 | 36.97 Million CNY | 368.8% |
| 2019 Q1 | 7.88 Million CNY | -81.26% |
| 2018 FY | 106.71 Million CNY | 49.19% |
| 2018 Q4 | 42.09 Million CNY | 0.0% |
| 2017 FY | 71.52 Million CNY | 170.79% |
| 2016 FY | 26.41 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shenzhen Lifotronic Technology Co., Ltd. | 345.04 Million CNY | 52.985% |